Aquestive Therapeutics (AQST) Net Margin Growth (1y) (2018 - 2026)

Aquestive Therapeutics (AQST) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 372.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -82.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -538.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -2,930.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2,292.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -146.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -2,359.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1,181.00
10 Aquestive Therapeutics 488.60 Mn 377.87 Mn 10.98 Mn 20,719.00

Historic Data

Download Data
DateValue
Mar 31, 2026 20,719.00
Dec 31, 2025 24,786.00
Sep 30, 2025 -3,562.00
Jun 30, 2025 -12,178.00
Mar 31, 2025 -15,653.00
Dec 31, 2024 -8,230.00
Sep 30, 2024 -6,934.00
Jun 30, 2024 3,009.00
Mar 31, 2024 -17,889.00
Dec 31, 2023 5,421.00
Sep 30, 2023 9,371.00
Jun 30, 2023 16,003.00
Mar 31, 2023 18,021.00
Dec 31, 2022 14,565.00
Sep 30, 2022 18.00
Jun 30, 2022 41,458.00
Mar 31, 2022 7,566.00
Dec 31, 2021 -668.00
Sep 30, 2021 30,423.00
Jun 30, 2021 -15,155.00